These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9151308)

  • 21. Batten's disease: eight genes and still counting?
    Mole SE
    Lancet; 1999 Aug; 354(9177):443-5. PubMed ID: 10465165
    [No Abstract]   [Full Text] [Related]  

  • 22. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palmitoyl-protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis.
    Hofmann SL; Lee LA; Lu JY; Verkruyse LA
    Neuropediatrics; 1997 Feb; 28(1):27-30. PubMed ID: 9151316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of chromosome 16 markers in the differential diagnosis of neuronal ceroid-lipofuscinosis.
    Taschner PE; de Vos N; Catsman-Berrevoets CE; van Duinen SG; Lindhout D; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):338-43. PubMed ID: 7668359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linkage analysis of late-infantile neuronal ceroid-lipofuscinosis.
    Sharp J; Savukoski M; Wheeler RB; Harris J; Järvelä I; Peltonen L; Gardiner M; Williams R
    Am J Med Genet; 1995 Jun; 57(2):348-9. PubMed ID: 7668361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal ceroid-lipofuscinoses in childhood.
    Rapola J
    Perspect Pediatr Pathol; 1993; 17():7-44. PubMed ID: 8316528
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of Batten disease candidate genes STP and STM.
    Munroe PB; Mitchison HM; Dooley TP; Gardiner RM; Mole SE
    Am J Med Genet; 1995 Jun; 57(2):324-6. PubMed ID: 7668356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of Bcl-2 and elevation of ceramide in Batten disease.
    Puranam K; Qian WH; Nikbakht K; Venable M; Obeid L; Hannun Y; Boustany RM
    Neuropediatrics; 1997 Feb; 28(1):37-41. PubMed ID: 9151319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Batten disease].
    Eto Y
    Ryoikibetsu Shokogun Shirizu; 1996; (15):241-3. PubMed ID: 9048000
    [No Abstract]   [Full Text] [Related]  

  • 30. The ovine model of neuronal ceroid lipofuscinosis (NCL): its contribution to understanding the pathogenesis of Batten disease.
    Jolly RD
    Neuropediatrics; 1997 Feb; 28(1):60-2. PubMed ID: 9151325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of genes from the Batten candidate region using exon amplification. Batten Disease Consortium.
    Lerner TJ; D'Arigo KL; Haines JL; Doggett NA; Taschner PE; de Vos N; Buckler AJ
    Am J Med Genet; 1995 Jun; 57(2):320-3. PubMed ID: 7668355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular basis of GROD-storing neuronal ceroid lipofuscinoses in Scotland.
    Stephenson JB; Greene ND; Leung KY; Munroe PB; Mole SE; Gardiner RM; Taschner PE; O'Regan M; Naismith K; Crow YJ; Mitchison HM
    Mol Genet Metab; 1999 Apr; 66(4):245-7. PubMed ID: 10191109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human forms of neuronal ceroid-lipofuscinosis (Batten disease): consensus on diagnostic criteria, Hamburg 1992.
    Kohlschütter A; Gardiner RM; Goebel HH
    J Inherit Metab Dis; 1993; 16(2):241-4. PubMed ID: 8411970
    [No Abstract]   [Full Text] [Related]  

  • 34. [Kufs' disease].
    Nagasato K
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):258-61. PubMed ID: 12483876
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurophysiological findings in neuronal ceroid lipofuscinoses.
    Sainio K
    Neuropediatrics; 1997 Feb; 28(1):70. PubMed ID: 9151328
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical and molecular analysis of Japanese patients with neuronal ceroid lipofuscinosis.
    Oishi K; Ida H; Kurosawa K; Eto Y
    Mol Genet Metab; 1999 Apr; 66(4):344-8. PubMed ID: 10191127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stengel-Batten-Spielmayer-Vogt disease].
    Diderichsen J
    Tidsskr Nor Laegeforen; 2004 Apr; 124(7):914. PubMed ID: 15060634
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary sediment dolichols in the diagnosis of neuronal ceroid-lipofuscinosis.
    Wolfe LS; Palo J; Santavuori P; Andermann F; Andermann E; Jacob JC; Kolodny E
    Ann Neurol; 1986 Mar; 19(3):270-4. PubMed ID: 3963771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refined localization of the Batten disease gene (CLN3) by haplotype and linkage disequilibrium mapping to D16S288-D16S383 and exclusion from this region of a variant form of Batten disease with granular osmiophilic deposits.
    Mitchison HM; O'Rawe AM; Lerner TJ; Taschner PE; Schlumpf K; D'Arigo K; de Vos N; Gormally E; Phillips HA; Thompson AD
    Am J Med Genet; 1995 Jun; 57(2):312-5. PubMed ID: 7668353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetic analysis of neuronal ceroid lipofuscinosis.
    Mole SE; Gardiner M
    Int J Neurol; 1991-1992; 25-26():52-9. PubMed ID: 11980063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.